212 related articles for article (PubMed ID: 15030594)
1. Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study.
El-Mofty M; Mostafa W; Esmat S; Youssef R; Bousseila M; Nagi N; Shaker O; Abouzeid A
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):93-100. PubMed ID: 15030594
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
3. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis.
El-Mofty M; Mostafa W; El-Darouty M; Bosseila M; Nada H; Yousef R; Esmat S; El-Lawindy M; Assaf M; El-Enani G
Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):148-56. PubMed ID: 15144393
[TBL] [Abstract][Full Text] [Related]
4. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
6. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
[TBL] [Abstract][Full Text] [Related]
7. Low-dose UVA₁ phototherapy for scleroderma: what benefit can we expect?
Pereira N; Santiago F; Oliveira H; Figueiredo A
J Eur Acad Dermatol Venereol; 2012 May; 26(5):619-26. PubMed ID: 21635565
[TBL] [Abstract][Full Text] [Related]
8. UVA/UVB phototherapy for atopic dermatitis revisited.
Valkova S; Velkova A
J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
[TBL] [Abstract][Full Text] [Related]
9. Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study.
Shalaby SM; Bosseila M; Fawzy MM; Abdel Halim DM; Sayed SS; Allam RS
Lasers Med Sci; 2016 Nov; 31(8):1707-1715. PubMed ID: 27510285
[TBL] [Abstract][Full Text] [Related]
10. Low-dose broad-band UVA in morphea using a new method for evaluation.
El-Mofty M; Zaher H; Bosseila M; Yousef R; Saad B
Photodermatol Photoimmunol Photomed; 2000 Apr; 16(2):43-9. PubMed ID: 10823310
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
12. Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures.
Kitamura Y; Namikawa H; Hayashi S; Yoshida T; Suzuki T; Hamasaki Y; Yamazaki S; Hatamochi A
Arch Dermatol Res; 2009 Aug; 301(7):507-13. PubMed ID: 19343355
[TBL] [Abstract][Full Text] [Related]
13. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression.
Kuo YR; Jeng SF; Wang FS; Chen TH; Huang HC; Chang PR; Yang KD
Lasers Surg Med; 2004; 34(2):104-8. PubMed ID: 15004820
[TBL] [Abstract][Full Text] [Related]
14. Significant downregulation of transforming growth factor-beta signal transducers in human skin following ultraviolet-A1 irradiation.
Gambichler T; Skrygan M; Tomi NS; Breuksch S; Altmeyer P; Kreuter A
Br J Dermatol; 2007 May; 156(5):951-6. PubMed ID: 17381457
[TBL] [Abstract][Full Text] [Related]
15. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
[TBL] [Abstract][Full Text] [Related]
16. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
17. Effects of low dose ultraviolet A-1 phototherapy on morphea.
Gruss CJ; Von Kobyletzki G; Behrens-Williams SC; Lininger J; Reuther T; Kerscher M; Altmeyer P
Photodermatol Photoimmunol Photomed; 2001 Aug; 17(4):149-55. PubMed ID: 11499534
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
19. Intense pulsed light effects on the expression of extracellular matrix proteins and transforming growth factor beta-1 in skin dermal fibroblasts cultured within contracted collagen lattices.
Wong WR; Shyu WL; Tsai JW; Hsu KH; Pang JH
Dermatol Surg; 2009 May; 35(5):816-25. PubMed ID: 19389097
[TBL] [Abstract][Full Text] [Related]
20. Narrowband UVB phototherapy for small plaque parapsoriasis.
Aydogan K; Karadogan SK; Tunali S; Adim SB; Ozcelik T
J Eur Acad Dermatol Venereol; 2006 May; 20(5):573-7. PubMed ID: 16684286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
